India has approved crucial amendments in the WTO agreement on trade-related intellectual property rights (TRIPS) enabling governments to break the monopoly of manufacturers of patented drugs by allowing compulsory licensing during emergencies. At the Doha ministerial meeting in 2001, World Trade Organisation members had decided to amend article 31 of trips to provide compulsory licenses. The decision to approve the amendment to article 31 of the TRIPS agreement was taken by the cabinet committee on WTO, |